Apontis Pharma AG

XETRA:APPH Germany Drug Manufacturers - Specialty & Generic

Market Cap

$94.06 Million

€91.63 Million EUR

Market Cap Rank

#27847 Global

#3046 in Germany

Share Price

€11.00

Change (1 day)

+0.00%

52-Week Range

€10.75 - €12.10

All Time High

€26.90

Apontis Pharma AG - Asset Resilience Ratio

Latest as of June 2023: -1.20%

Apontis Pharma AG (APPH) has an Asset Resilience Ratio of -1.20% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€-643.20K

Cash + Short-term Investments

Total Assets

€53.45 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2023)

This chart shows how Apontis Pharma AG's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Apontis Pharma AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€-643.20K	-1.2%
Total Liquid Assets	€-643.20K	-1.20%

Asset Resilience Insights

Limited Liquidity: Apontis Pharma AG maintains only -1.20% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.